FIDSON Announces Award of Contract by GSK Nigeria Plc as Local Manufacturing Partner


Thursday, April 25, 2019 11:15AM / NSE

GSK, in line with the restructuring of its supply chain operating model, has selected Fidson Healthcare Plc (“Fidson") as its preferred local contract manufacturing partner to take effect from the third quarter of 2021.

With this development, Fidson Healthcare Plc is poised to increase the capacity utilization of its ultramodern manufacturing facility at Otta, Ogun State and by extension its profitability. Fidson envisages that all necessary regulatory approvals would be obtained to execute the contract successfully.

The selection process which commenced about two years ago ended on Friday, the 12th of April 2019 with a signing ceremony at the Corporate Head Office of GSK Nigeria in Lagos.


About GlaxoSmithKline Consumer Nigeria PLC

An affiliate of GlaxoSmithKline Plc, GlaxoSmithKline Consumer Nigeria PLC (GSK Nigeria) is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information, see


About Fidson Healthcare PLC

Fidson Healthcare Plc is a leading pharmaceutical manufacturing company in Nigeria. Founded in 1995, the company is built on the five core values of Innovation, Excellence, Passion, Integrity and Ownership and is relentlessly pursuing its goal of becoming a leading player in the pharmaceutical landscape in Nigeria. 


Visit Fidson Healthcare Plc IR Page  in Proshare MARKETS

Graph 1: Fidson Healthcare Plc – One Year Share Price Movement


 Proshare Nigeria Pvt. Ltd. 


Table: Audited 2018 Results

Proshare Nigeria Pvt. Ltd. 


Related News

1.      Fidson Healthcare Plc - Still Set to Deliver Value to Shareholders

2.      FIDSON Rights Issue To Open March 06, 2019

3.      FIDSON Obtains SEC Approval To Issue A Revised Rights Issue Circular

4.      FIDSON Declares N521.40m PAT in Q2 2018 Results,(SP:N6.15k)

5.      FIDSON Declares N202.80m PAT in Q1 2018 Result,(SP:N5.46k)

6.      FIDSON Declares N1.06bn PAT in 2017 Audited Results,(SP:N5.70k)

7.      Fidson Healthcare Plc Appoints Mr Olusegun S Adebanji as Director

8.      FIDSON Declares N730.45 mln PAT in Q3 2017 Result,(SP:N3.36k)

9.      Fidson Healthcare Plc New plant is Delivering Enormous Value

10.  FIDSON Declares N466.09 mln PAT in Q2 2017 Result,(SP:N2.94k)


Related News